DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $144,000 | -25.4% | 30,595 | +13.2% | 0.00% | -50.0% |
| Q2 2015 | $193,000 | +31.3% | 27,020 | +55.8% | 0.00% | +100.0% |
| Q1 2015 | $147,000 | +6.5% | 17,340 | +16.8% | 0.00% | 0.0% |
| Q4 2014 | $138,000 | -22.0% | 14,850 | -30.1% | 0.00% | -50.0% |
| Q3 2014 | $177,000 | +13.5% | 21,240 | +57.7% | 0.00% | 0.0% |
| Q2 2014 | $156,000 | -11.9% | 13,470 | -3.6% | 0.00% | 0.0% |
| Q1 2014 | $177,000 | -56.7% | 13,980 | -63.0% | 0.00% | -60.0% |
| Q4 2013 | $409,000 | – | 37,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |